Literature DB >> 2806326

A gamma camera method to monitor the use of degradable starch microspheres in hepatic arterial chemotherapy.

A Britten1, A Flowerdew, T Hunt, I Taylor, D Ackery, J Fleming.   

Abstract

A gamma camera method to quantify the haemodynamic effects of degradable starch microspheres (DSM) in intra arterial hepatic therapy is described. Results are presented from ten patients with colorectal liver metastases. Intra hepatic arterio venous shunting was present in 1 patient prior to DSM and in 2 subjects after three 300 mg DSM fractions. DSM reduced the rate of flow of injectate to the lung in all cases. Conversely, an increased rate of flow of injectate to gut or spleen occurred with 300 mg fractions of DSM in 7/9 cases. Lower dose DSM fractions are indicated. At 2-3 min after DSM injection the mean fraction of the activity retained in the liver was 0.22. A DSM induced enhancement of tumour relative to normal tissue perfusion was obtained in four out of five tumour regions identified. All indices showed a wide variation between patients and between individual DSM doses, and the high incidence of extra hepatic shunting confirms the need for monitoring when using intra arterial microspheres.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2806326     DOI: 10.1007/bf00251678

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  12 in total

1.  Re: Quantitative hepatic arterial perfusion scintigraphy and starch microspheres in cancer therapy.

Authors:  P E Valk; J Guille; P Crea
Journal:  J Nucl Med       Date:  1984-06       Impact factor: 10.057

2.  Gastric air contrast: useful adjunct to hepatic artery scintigraphy.

Authors:  R L Wahl; H A Ziessman; J Juni; D Lahti
Journal:  AJR Am J Roentgenol       Date:  1984-08       Impact factor: 3.959

3.  Atlas of hepatic arterial perfusion scintigraphy.

Authors:  H A Ziessman; J W Gyves; J E Juni; F L Wahl; J H Thrall; W D Ensminger; H A Goldstein; V Dubiansky
Journal:  Clin Nucl Med       Date:  1985-09       Impact factor: 7.794

4.  Improved regional selectivity of hepatic arterial BCNU with degradable microspheres.

Authors:  S Dakhil; W Ensminger; K Cho; J Niederhuber; K Doan; R Wheeler
Journal:  Cancer       Date:  1982-08-15       Impact factor: 6.860

5.  Enhanced drug retention in VX2 tumors by use of degradable starch microspheres.

Authors:  L E Lorelius; A R Benedetto; R Blumhardt; H V Gaskill; J L Lancaster; H Stridbeck
Journal:  Invest Radiol       Date:  1984 May-Jun       Impact factor: 6.016

6.  Reduction of hepatic arterial flow by degradable microspheres in patients with liver tumor.

Authors:  L Thulin; G Tydén; B Nyberg; B Calissendorff; R Hultcrantz
Journal:  Acta Chir Scand       Date:  1986 Jun-Jul

7.  Temporary blood flow stasis with degradable starch microspheres (DSM) for liver metastases in a rat model.

Authors:  A D Flowerdew; H K Richards; I Taylor
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

8.  Quantitative hepatic arterial perfusion scintigraphy and starch microspheres in cancer chemotherapy.

Authors:  H A Ziessman; J H Thrall; J W Gyves; W D Ensminger; J E Niederhuber; M Tuscan; S Walker
Journal:  J Nucl Med       Date:  1983-10       Impact factor: 10.057

9.  Studies in pharmacokinetics and tolerance of substances temporarily retained in the liver by microsphere embolization.

Authors:  B Lindell; K F Aronsen; B Nosslin; U Rothman
Journal:  Ann Surg       Date:  1978-01       Impact factor: 12.969

10.  Improved regional selectivity of hepatic arterial mitomycin by starch microspheres.

Authors:  J W Gyves; W D Ensminger; D VanHarken; J Niederhuber; P Stetson; S Walker
Journal:  Clin Pharmacol Ther       Date:  1983-08       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.